Dr. Marios Giannakis, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $133,334 | 2 | 95.1% |
| Consulting Fee | $2,855 | 2 | 2.0% |
| Honoraria | $2,000 | 1 | 1.4% |
| Unspecified | $1,821 | 3 | 1.3% |
| Food and Beverage | $131.44 | 2 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $133,334 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $2,061 | 2 | $0 (2023) |
| ChromaCode, Inc | $2,000 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,821 | 3 | $0 (2020) |
| AstraZeneca UK Limited | $925.00 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $4,061 | 3 | AstraZeneca Pharmaceuticals LP ($2,061) |
| 2020 | $1,678 | 2 | Novartis Pharmaceuticals Corporation ($1,678) |
| 2019 | $66,667 | 1 | Genentech, Inc. ($66,667) |
| 2018 | $67,735 | 4 | Genentech, Inc. ($66,667) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2023 | ChromaCode, Inc | — | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| 05/14/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| 04/28/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $6.44 | General |
| 01/30/2020 | Novartis Pharmaceuticals Corporation | LGK974 (Drug) | — | In-kind items and services | $178.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | LGK974 (Drug) | — | In-kind items and services | $1,500.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT | ||||||
| 07/01/2019 | Genentech, Inc. | — | Grant | Cash or cash equivalent | $66,667.00 | General |
| 07/10/2018 | AstraZeneca UK Limited | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Oncology | ||||||
| 07/03/2018 | Genentech, Inc. | — | Grant | Cash or cash equivalent | $66,667.00 | General |
| 04/15/2018 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 01/23/2018 | Novartis Pharmaceuticals Corporation | WNT974 (Drug) | — | In-kind items and services | $143.25 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $1,678 | 2 |
| RESEARCH RELATED PUBLICATION SUPPORT | Novartis Pharmaceuticals Corporation | $143.25 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 54 | 82 | $47,306 | $8,971 |
| 2022 | 1 | 18 | 48 | $34,205 | $5,605 |
| 2021 | 3 | 51 | 99 | $57,485 | $11,828 |
| 2020 | 2 | 40 | 90 | $41,094 | $8,502 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 32 | $23,416 | $3,799 | 16.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 22 | $8,778 | $2,235 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $10,664 | $1,856 | 17.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 16 | $4,448 | $1,081 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 48 | $34,205 | $5,605 | 16.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 28 | 66 | $40,252 | $8,255 | 20.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 22 | $8,778 | $1,972 | 22.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $8,455 | $1,600 | 18.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 26 | 66 | $32,766 | $6,297 | 19.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 24 | $8,328 | $2,204 | 26.5% |
About Dr. Marios Giannakis, MD
Dr. Marios Giannakis, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2009. The National Provider Identifier (NPI) number assigned to this provider is 1417185729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marios Giannakis, MD has received a total of $140,142 in payments from pharmaceutical and medical device companies, with $4,061 received in 2023. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Grant" ($133,334).
As a Medicare-enrolled provider, Giannakis has provided services to 163 Medicare beneficiaries, totaling 319 services with total Medicare billing of $34,904. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Medical Oncology
- Location Boston, MA
- Active Since 06/25/2009
- Last Updated 06/27/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1417185729
Products in Payments
- LGK974 (Drug) $1,678
- IMFINZI (Drug) $800.00
- WNT974 (Drug) $143.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Boston
Ilena George, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $315,946
Gabriela Cobos, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $205,549
Nishant Suneja, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $144,193
Dr. Marlise Luskin, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $139,788
Dr. Josue Villegas Galaviz, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $122,824
Dr. Kyle Williams, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $106,982